Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Convertible Debt (2017 - 2025)

Dexcom (DXCM) has disclosed Convertible Debt for 9 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Convertible Debt changed 0.32% to $1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 billion, a 0.32% change, with the full-year FY2025 number at $1.2 billion, changed 0.32% from a year prior.
  • Convertible Debt was $1.2 billion for Q4 2025 at Dexcom, roughly flat from $1.2 billion in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $2.4 billion in Q3 2024 to a low of $1.2 billion in Q4 2022.
  • A 5-year average of $1.8 billion and a median of $1.8 billion in 2021 define the central range for Convertible Debt.
  • Biggest YoY gain for Convertible Debt was 103.25% in 2024; the steepest drop was 49.18% in 2024.
  • Dexcom's Convertible Debt stood at $2.0 billion in 2021, then crashed by 39.57% to $1.2 billion in 2022, then soared by 103.24% to $2.4 billion in 2023, then tumbled by 49.18% to $1.2 billion in 2024, then grew by 0.32% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for DXCM's Convertible Debt are $1.2 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.2 billion (Q2 2025).